Text Size

Time to Perform Lung Function Test in Cystic Fibrosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cecilia Rodriguez, Karolinska University Hospital
ClinicalTrials.gov Identifier:
NCT01737801
First received: November 19, 2012
Last updated: November 29, 2012
Last verified: November 2012
History of Changes
  Purpose

Time to perform lung function test after chest physiotherapy in cystic fibrosis.

The investigators study FEV1(forced expiratory volume in one second) and FVC (forced vital capacity).


Condition Intervention
Cystic Fibrosis
 Procedure: Lung function test

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Time to Perform Lung Function Test in Cystic Fibrosis After Chest Physiotherapy.

Resource links provided by NLM:

MedlinePlus related topics: Cystic Fibrosis
U.S. FDA Resources

Further study details as provided by Karolinska University Hospital:

Primary Outcome Measures:
  • Lung function test. FEV1 and FVC [ Time Frame: 2 days ] [ Designated as safety issue: Yes ]

Enrollment: 24
Study Start Date: February 2008
Study Completion Date: September 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lung function test
Lung function test
 Procedure: Lung function test
Lung function test.
Other Name: Lung function test.

Detailed Description:

The patients perform spirometry before, direct after, 30 minutes, 1 hour, 2 hours, and 3 hours after physiotherapist. The investigators want to study the FEV1 and FVC.

  Eligibility

Ages Eligible for Study:   5 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with cystic fibrosis

Exclusion Criteria:

  • patients with cystic fibrosis who could not stay at the clinic for more than 4 hrs.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01737801

Locations
Sweden
Karolinska University Hospital
Stockholm, Sweden
Sponsors and Collaborators
Karolinska University Hospital
Investigators
Principal Investigator: Cecilia Rodriguez, Physio Karolinska Institutet
  More Information

No publications provided

Responsible Party: Cecilia Rodriguez, Physiotherapist, Karolinska University Hospital
ClinicalTrials.gov Identifier: NCT01737801     History of Changes
Other Study ID Numbers: 2012-CF-2
Study First Received: November 19, 2012
Last Updated: November 29, 2012
Health Authority: Sweden: Regional Ethical Review Board

Keywords provided by Karolinska University Hospital:
Lung function
Physiotherapy

Additional relevant MeSH terms:
Cystic Fibrosis
Fibrosis
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
 Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 19, 2013